# IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia

> **NCT01200069** · PHASE4 · TERMINATED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 14 (actual)

## Conditions studied

- Depression, Myalgia

## Interventions

- **DRUG:** Placebo infusion
- **DRUG:** ibuprofen intravenous

## Key facts

- **NCT ID:** NCT01200069
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** unable to increase to target enrollment
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01200069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01200069, "IV Ibuprofen for Post-Electroconvulsive Therapy Myalgia". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT01200069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*